Sumitomo Dainippon Pharma Co., Ltd. announced the appointment of Tsukasa Kiriyama, whose current position is Director, Oncology Clinical Development Unit, to the position of Senior Advisor, Drug Development as of April 1, 2015. The company also announced the following personnel changes to its Sales & Marketing (Division). The company appointed Kazushige Oba, whose current position is Director, Osaka Branch II, Nishi-Nippon Region, to the position of Director, Kobe Branch, Nishi-Nippon Region, and Haruo Kusakabe, whose current position is Group Manager, Osaka Group II, Psychiatry Kinki-Tokai Region, Nishi-Nippon Region, to the position of Director, Osaka Branch II, Nishi-Nippon Region, effective April 1, 2015.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
377 JPY | +3.86% | -5.75% | -19.10% |
May. 07 | Profit-Taking, China Outlooks Churn Asian Stock Markets | MT |
May. 02 | Fed Outlook, Earnings Season Roil Asian Stock Markets | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.10% | 927M | |
+32.63% | 698B | |
+26.51% | 568B | |
-4.62% | 358B | |
+19.16% | 328B | |
+3.60% | 283B | |
+16.34% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+8.48% | 165B |
- Stock Market
- Equities
- 4506 Stock
- News Sumitomo Pharma Co., Ltd.
- Sumitomo Dainippon Pharma Co., Ltd. Announces Personnel Changes, Effective April 1, 2015